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CDiscussion
r W. Randolph Chitwood (Greenville, NC). Thank you, Dr
itchell. I rise first to congratulate Dr Damiano, Dr Lall, and their
ssociates for collating, analyzing and presenting these important
ata. Dr Lall, your presentation was absolutely excellent. I re-
iewed the manuscript in detail in advance and have several
omments and a few questions.
Clearly, Dr Jim Cox established the gold standard for a proce-
ure to relieve patients of AF, both intermittent and continuous
F. The seminal investigative and clinical work of Dr Cox and Dr
onieau at Washington University eventuated in the CM III pro-
edure, which was described first in the Journal of Cardiothoracic
nd Vascular Surgery in 1995, also bears mention. Through de-
ailed intraoperative mapping, he finally settled on an effective
ight and left atrial incision set that relieved more than 95% of
atients from AF. New lesion sets in the CM III procedure at that
ime improved both right and left atrial transport and decreased the
eed for pacemakers. Despite these impressive results, the com-
lexity of creating surgical lesions and the morbidity, especially in
nexperienced hands, precluded the widespread adoption of the
M III procedure, despite these obvious advantages that Dr Lall
as shown us. This is especially true when combined with mitral
alve surgery and mitral valve repair.
Dr Damiano’s work has continued in this illustrious shadow,
ith attempts to determine an effective operative method that most
urgeons can perform in a reasonable time with minimal compli-
ations. The procedure described in this presentation used bipolar
F ablation, with most lesions approximating those of the CM III
rocedure. However, there were differences in the lesion sets.
The authors have compared 154 patients undergoing traditional
ut-and-sew operations with 88 patients undergoing the new op-
ration, which has been dubbed here as the CM IV procedure.
ecause a serial patient series was reviewed retrospectively, the
uthors used a propensity score analysis to select matched cohorts
or comparison. This method yielded 58 patients in the cut-and-
ew group and 58 patients in the bipolar RF or CM IV group.
atients had either lone AF, or it was combined with valvular or
oronary disease, and therefore they really were not all the same.
hey determined that more than 90% in both groups were relieved
f AF, suggesting that this new method could supersede the
raditional operation as a standard. There was no statistical differ-
nce between the groups as far as relief from AF. In the CM IV
roup 12% more patients continue to receive antiarrhythmics, but
ollow-up was 4 years less than in the CM III group.
A weakness of this study, of course, is the retrospective review,
hich we are all forced to do, and the small number of patients in
ach final comparative cohort. However, these seem inescapable
onsidering the evolutionary nature of these methods.
Our results confirm the data presented. In an attempt to render
n effective, minimally invasive, small-incision AF operation, we
eveloped an endoscopic method using cryoablative lesions at
150°C. In 161 patients either with lone AF or combined with
itral valve disease, we approximated the lesion set described by
r Lall. Of the 41 patients with lone AF, either intermittent or
ontinuous, 92% were AF free 3 months without drugs and 2
ontinued to receive antiarrhythmics, suggesting that a full lesion
et, as you suggested, is optimal and that these operations are safe
nd efficient. We had no mortality in the lone AF group, and 13% d
The Journal of Thoracicequired pacemakers, as you have shown here. I have several
uestions for you.
This commentator applauds you for confirming electrical iso-
ation of pulmonary veins by pacing and mapping for exit block. I
hink this is important. Would it have been possible to determine
solation of the right side and other parts of the right atrium? Does
t matter if we isolate the right atrium? Why do the right side at all
f there is no AF?
Would you like me to go ahead and ask all my questions, or let
er answer them one at a time?
Dr Mitchell. Let’s go one at a time.
Dr Lall. Thank you, Dr Chitwood, for your kind comments and
uestions. It is an honor to have you discuss our article, and we
ecognize the many achievements of your group in pioneering
inimally invasive AF surgery.
To address your first question on confirmation of conduction
lock, we can use computerized mapping techniques and multiple
lectrodes to confirm conduction block, but this is difficult to do in
he operative setting; it is very time consuming and not practical.
he other way to confirm isolation is with pacing or recording of
ndividual electrocardiograms. This would require a portion of the
trium to be completely electrically isolated from the remainder of
he atrium, and in the CM lesion sets, this only occurs around the
ulmonary veins.
In terms of the right atrial lesions, we do believe that it is
mportant to perform a biatrial lesion set because mapping studies
ave shown that between 10% and 30% of patients with AF have
right atrial focus.
Dr Khargi, in the Journal of European Cardiothoracic Surgery
n 2005, showed in a univariate analysis that sinus rhythm con-
ersion rates were higher in the biatrial lesion set group, and also
r Niv Ad has shown this in a meta-analysis. Finally, without any
ight atrial lesions, there will be an incidence of late atrial flutter of
bout 10% to 20% in most series.
Dr Chitwood. Therefore you are suggesting we always do the
ight side.
What is the rationale for isolating the pulmonary veins in 2
slands rather than as 1 continual island?
Dr Lall. The bipolar clamp device that we use makes it
mpossible to encircle all 4 pulmonary veins at once. Therefore we
solate the right and left pulmonary veins separately, and then a
esion across the inferior posterior left atrium is completed. In
atients with an atrium larger than 5 cm, we would place a second
esion that would connect with the superior aspect of the pulmo-
ary vein lesions.
Dr Chitwood. Therefore it is mainly related to the device, is
hat correct?
Dr Lall. Yes.
Dr Chitwood. And I think I will yield my last 2 questions. My
ast question will be this: What percentage of your patients re-
uired a second electrophysiologic study for flutter? Did you have
uch flutter develop after these procedures?
Dr Lall. We did not have any reoperations for atrial flutter.
Dr Chitwood. Even in the catheterization laboratory?
Dr Lall. Correct.
Dr Chitwood. I thank the Association for the opportunity toiscuss this fine article.
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CDDr John Stulak (Rochester, Minn). What was your method of
hythm assessment for these patients during their clinical follow-
p? Was it telephone interview, electrocardiogram, Holter moni-
or, etc?
Dr Lall. In the CM III group we did a retrospective follow-up
hrough a mailed questionnaire or telephone interview, as well as
aving contact with either their cardiologist or primary care phy-
ician regarding recurrence of AF. In patients who complained of
rrhythmia recurrence, copies of an electrocardiogram and Holter
onitoring were obtained. In the CM IV group an electrocardio-
ram was obtained at scheduled 1-, 3-, 6-, and 12-month follow-up
ppointments. Our study had 100% follow-up in this group. Pa-
ients unable to return to our clinic were contacted by telephone,
nd electrocardiograms from their referring physicians were ob-
ained. A 24-hour Holter monitor or event recorder was obtained
n each patient with any symptoms or palpitations.
Dr Syed Tasnim Raza (Parkersburg, WV). Dr Lall, I wanted
o congratulate you on a very fine presentation. When Dr Cox
oved from St Louis to Washington, he changed from doing all
ut-and-sew maze procedures to cryoablation, using a long cryo-
blation probe, the procedure he called cryo-maze, and I wanted to
sk, how does your CM IV procedure differ from the cryo-maze
rocedure? My second question is this: you used 2 separate bipolar o
96 The Journal of Thoracic and Cardiovascular Surgery ● FebrF technologies, the Medtronic and the Atricure. Was there any
ifference between the results in those 2, and have you compared
hem?
Thank you very much.
Dr Lall. I am unsure of how the cryo-maze procedure com-
ares with our CM IV procedure.
For your second question, the Atricure device was used for 57
f the 58 patients, and the Medtronic device was used for only 2
atient. We did not look for any difference between the 2 devices.
Dr Craig R. Smith (New York, NY). I am curious how much
verlap there was during the period of the study between the 2
rocedures. You would think that a procedure with such a dramat-
cally reduced crossclamp time would quickly replace its prede-
essor if it seemed even close to equivalent. If there was little
verlap, I would not think you would need to do a propensity
nalysis.
Dr Lall. We no longer do the CM III procedure at Barnes-
ewish. There was no overlap between the 2 procedures. Thus to
ompare these 2 nonrandomized groups, a propensity analysis was
one.
Dr Smith. I understand. I just could not see as much of a
ationale for it if they were really just one procedure following the
ther. Point made.
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